The George Institute For Global Health
United Kingdom

News and Events

One quarter of the world’s adult population suffers from hypertension, and although it has no obvious symptoms, it can lead to heart attacks, stroke, kidney failure and blindness. Despite this, there has been great uncertainty as to how intensively blood pressure should be lowered to obtain maximal benefit and minimize risks.

Two thirds of younger, working age stroke survivors face economic hardship and are often forced to use savings or sell assets to pay basic living expenses, a new Australian study has found.

Media release: 

Most Australian women are unaware that heart disease is their biggest killer and they are more likely to die from a second heart attack than men.

Professor Chris Maher, Director of the Musculoskeletal Division at The George Institute for Global Health, said that the new back pain tool — Back Pain Choices — synthesises recommendations from evidence-based practice guidelines in Australia, the UK and USA into a unified set of recommendations.

The ADVANCE study assessed over 10,000 people living with type 2 diabetes across 20 countries. The study has identified the benefits of tight blood pressure and blood glucose control for people with diabetes, and has influenced guidelines for diabetes care globally.

Motivated by the chance to deliver better health outcomes for Indigenous populations, Sharon Ponniah joined The George Institute in 2012 as Program Manager for the Kanyini Vascular Collaboration.

Mary Anne Land joined The George Institute for Global Health in 2010. Not even 12 months after completing her Masters in Public Health in her hometown of Wollongong NSW, she now finds herself completing an internship at The World Health Organization (WHO) in Geneva.

As I move towards 50, I think more about my age than I used to. And it’s not entirely encouraging.I hurtle around the sun, clock up the years and head unswervingly towards the inevitable. Or do I?

Kidney failure shortens the life of affected people, reduces quality of life and is expensive to treat. Prevention is key, as relatively few treatments have been shown to be effective.

For some time, medical experts have relied on a commonly used marker to treat a patient’s risk of cardiovascular events such as heart attack or stroke. New research recently published in the British Medical Journal by The George Institute for Global Health has clearly shown that this widely used treatment in people with kidney disease is not effective.